Ginsenoside Rg3, a minor tetracyclic triterpenoid saponin extracted from ginseng, inhibits VM in pancreatic cancer (PC) cells by targeting the VE-cadherin/EphA2/MMP2/MMP9 signaling axis. The gene discussed is CDH5; the disease is pachyonychia congenita.